CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000378 | has_active_moiety | C3817393 | droxidopa | droxidopa 200 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_ingredient | C3818596 | droxidopa | droxidopa 300 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_moiety | C3818596 | droxidopa | droxidopa 300 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_ingredient | C3818597 | droxidopa | droxidopa 200 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_moiety | C3818597 | droxidopa | droxidopa 200 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_ingredient | C5442698 | droxidopa | DROXIDOPA 100 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_moiety | C5442698 | droxidopa | DROXIDOPA 100 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_ingredient | C5442699 | droxidopa | DROXIDOPA 200 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_moiety | C5442699 | droxidopa | DROXIDOPA 200 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_ingredient | C5442700 | droxidopa | DROXIDOPA 300 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_active_moiety | C5442700 | droxidopa | DROXIDOPA 300 ug ORAL CAPSULE | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3817052 | droxidopa | droxidopa 100 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3818596 | droxidopa | droxidopa 300 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3818597 | droxidopa | droxidopa 200 MG Oral Capsule [Northera] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3817146 | droxidopa | droxidopa 100 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3817392 | droxidopa | droxidopa 300 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3817393 | droxidopa | droxidopa 200 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | inverse_isa | C0042397 | droxidopa | Vasoconstrictor Agents | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | Drugs used to cause constriction of the blood vessels. |
C0000378 | has_member | C3654022 | droxidopa | Adrenergic and dopaminergic cardiac stimulants | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | isa | C3817146 | droxidopa | droxidopa 100 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | isa | C3817392 | droxidopa | droxidopa 300 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | isa | C3817393 | droxidopa | droxidopa 200 MG Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | isa | C3820386 | droxidopa | droxidopa Oral Product | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | isa | C4752986 | droxidopa | Droxidopa only product | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | inverse_isa | C0002520 | droxidopa | Amino Acids | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. |
C0000378 | inverse_isa | C5438544 | droxidopa | Alpha-adrenergic and beta-adrenergic agonist-containing product | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | parent_of | C2267088 | droxidopa | D [Preparations] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | tradename_of | C3817378 | droxidopa | Northera | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | structural_class_of | C0007412 | droxidopa | Catecholamines | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. |
C0000378 | therapeutic_class_of | C0007680 | droxidopa | Central Nervous System Agents | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into specific agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and nonspecific agents, those producing effects on different tar... |
C0000378 | has_contraindicated_drug | C0013182 | droxidopa | Drug Allergy | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | Immunologically mediated adverse reactions to medicinal substances used legally or illegally. |
C0000378 | may_be_treated_by | C0020651 | droxidopa | Hypotension, Orthostatic | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred ... |
C0000378 | physiologic_effect_of | C2917273 | droxidopa | Increased Blood Pressure [PE] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | physiologic_effect_of | C3536904 | droxidopa | Vasoconstriction [PE] | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820221 | droxidopa | droxidopa 300 MG | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820222 | droxidopa | droxidopa 200 MG | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820223 | droxidopa | droxidopa 100 MG | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820314 | droxidopa | droxidopa Oral Capsule | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820385 | droxidopa | droxidopa Pill | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000378 | has_ingredient | C3820386 | droxidopa | droxidopa Oral Product | A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. | null |
C0000379 | inverse_isa | C0018533 | 3,4-Methylenedioxyamphetamine | Hallucinogens | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experience... |
C0000379 | inverse_isa | C0242701 | 3,4-Methylenedioxyamphetamine | Serotonin Agents | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. |
C0000379 | inverse_isa | C0242978 | 3,4-Methylenedioxyamphetamine | Adrenergic uptake inhibitor | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drug... |
C0000379 | mapped_to | C0044110 | 3,4-Methylenedioxyamphetamine | 1-(2,3-methylenedioxyphenyl)-2-aminopropane | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0047006 | 3,4-Methylenedioxyamphetamine | 3,4-methylenedioxyethamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | a kind of hallucinogenic drug |
C0000379 | mapped_to | C0047007 | 3,4-Methylenedioxyamphetamine | 3,4-methylenedioxyphenylisobutylamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0066661 | 3,4-Methylenedioxyamphetamine | MMDA | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | a kind of hallucinogenic drug |
C0000379 | mapped_to | C0068016 | 3,4-Methylenedioxyamphetamine | N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0068075 | 3,4-Methylenedioxyamphetamine | N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0068077 | 3,4-Methylenedioxyamphetamine | N-methyl-3,4-methylenedioxyphenylisobutylamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0088750 | 3,4-Methylenedioxyamphetamine | 1-(3,4-methylenedioxyphenyl)-2-butanamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0257518 | 3,4-Methylenedioxyamphetamine | 3,4-methylenedioxyphenyl-1-ethanamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0379269 | 3,4-Methylenedioxyamphetamine | 6-hydroxy-N-methyl-3,4-methylenedioxyamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0607144 | 3,4-Methylenedioxyamphetamine | 3,4-methylenedioxyphenethylamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0640109 | 3,4-Methylenedioxyamphetamine | 3,4-isopropylidinedioxyamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0640112 | 3,4-Methylenedioxyamphetamine | 3,4-ethylenedioxyamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C0655659 | 3,4-Methylenedioxyamphetamine | 2-hydroxy-4,5-methylenedioxyamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C2742360 | 3,4-Methylenedioxyamphetamine | 2-ethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C2742361 | 3,4-Methylenedioxyamphetamine | 2-methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | mapped_to | C3657567 | 3,4-Methylenedioxyamphetamine | 5-((3,4-methylenedioxyphenylethane)methylamino)-1-p-hydroxyphenyl-1-penten-3-one | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | inverse_isa | C0002763 | 3,4-Methylenedioxyamphetamine | Central Nervous System Stimulants | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. |
C0000379 | subset_includes_concept | C1880653 | 3,4-Methylenedioxyamphetamine | FDA Established Names and Unique Ingredient Identifier Codes Terminology | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices. |
C0000379 | measures | C0801397 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Urine:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0801401 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Bld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0802439 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord:Screen | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0802440 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0803354 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Urine:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0942662 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Milk:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0942701 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Stool:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0943027 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Vitr fld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0943073 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Meconium:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C0945028 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C1542996 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Gast fld:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C1631781 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C2708816 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:SCnc:Pt:Ser/Plas:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C2924086 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C2970492 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Ser/Plas:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C2970493 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:XXX:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C3262477 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Meconium:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C3533429 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Saliva:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C3847274 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Saliva:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C3847275 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas/Bld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C4266167 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Hair:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C5452261 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:TissCo:Ord:Screen | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | measures | C5452262 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:TissCo:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | inverse_isa | C0002658 | 3,4-Methylenedioxyamphetamine | amphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms... |
C0000379 | inverse_isa | C0002667 | 3,4-Methylenedioxyamphetamine | Amphetamines | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation. |
C0000379 | inverse_isa | C1445631 | 3,4-Methylenedioxyamphetamine | Amphetamine and/or amphetamine derivative | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | inverse_isa | C3839662 | 3,4-Methylenedioxyamphetamine | Substituted amphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | Class of chemicals that are analogs or derivatives of 1-phenylpropan-2-amine, including synthetic and naturally occurring amphetamines. |
C0000379 | has_component | C1266616 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine measurement | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_measured_component | C1266616 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine measurement | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C1278214 | 3,4-Methylenedioxyamphetamine | Urine MDA screening test | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C1278241 | 3,4-Methylenedioxyamphetamine | Urine methylenedioxyamphetamine measurement | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_measured_component | C1278241 | 3,4-Methylenedioxyamphetamine | Urine methylenedioxyamphetamine measurement | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2188622 | 3,4-Methylenedioxyamphetamine | urine drug screen for methylenedioxyamphetamine (MDA) | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2585192 | 3,4-Methylenedioxyamphetamine | Measurement of methylenedioxymethamphetamine and methylenedioxyamphetamine | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3863661 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamines (MDA, MDEA, MDMA) | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3863661 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamines (MDA, MDEA, MDMA) | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C5386658 | 3,4-Methylenedioxyamphetamine | meconium analysis for methylenedioxyamphetamine by confirmatory method | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C5386727 | 3,4-Methylenedioxyamphetamine | methylenedioxyamphetamine in meconium | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.